Sarepta Therapeutics (SRPT) Posts Q2 Loss of 46c/Share

August 8, 2013 7:08 AM

Sarepta Therapeutics (NASDAQ: SRPT) reported Q2 EPS of ($0.46), $0.21 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found